TY - JOUR
T1 - From predictions to prescriptions
T2 - A data-driven response to COVID-19
AU - Bertsimas, Dimitris
AU - Boussioux, Leonard
AU - Cory-Wright, Ryan
AU - Delarue, Arthur
AU - Digalakis, Vassilis
AU - Jacquillat, Alexandre
AU - Kitane, Driss Lahlou
AU - Lukin, Galit
AU - Li, Michael
AU - Mingardi, Luca
AU - Nohadani, Omid
AU - Orfanoudaki, Agni
AU - Papalexopoulos, Theodore
AU - Paskov, Ivan
AU - Pauphilet, Jean
AU - Lami, Omar Skali
AU - Stellato, Bartolomeo
AU - Bouardi, Hamza Tazi
AU - Carballo, Kimberly Villalobos
AU - Wiberg, Holly
AU - Zeng, Cynthia
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.
PY - 2021/6
Y1 - 2021/6
N2 - The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic’s spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control’s pandemic forecast.
AB - The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic’s spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control’s pandemic forecast.
KW - COVID-19
KW - Epidemiological modeling
KW - Machine learning
KW - Optimization
UR - http://www.scopus.com/inward/record.url?scp=85100843493&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100843493&partnerID=8YFLogxK
U2 - 10.1007/s10729-020-09542-0
DO - 10.1007/s10729-020-09542-0
M3 - Article
C2 - 33590417
AN - SCOPUS:85100843493
SN - 1386-9620
VL - 24
SP - 253
EP - 272
JO - Health Care Management Science
JF - Health Care Management Science
IS - 2
ER -